Mark R Vossler, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12333 Ne 130th Lane, #320, Kirkland, WA 98034 Phone: 425-899-0555 Fax: 425-899-1333 |
William S Getchell, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12333 Ne 130th Lane, #320, Kirkland, WA 98034 Phone: 425-899-0555 Fax: 425-899-1333 |
Dr. Robert E Haynes, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 12333 Ne 130th Lane, #320, Kirkland, WA 98034 Phone: 425-899-0555 Fax: 425-899-1333 |
James S Schneider, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 12333 Ne 130th Lane, #320, Kirkland, WA 98034 Phone: 425-899-0555 Fax: 425-899-1333 |
Ali Sharifian, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12333 Ne 130th Ln Ste 320, Kirkland, WA 98034 Phone: 425-899-0555 |
Harry H Yu, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12333 Ne 130th Lane, #320, Kirkland, WA 98034 Phone: 425-899-0555 Fax: 425-899-1333 |
Rubin R Maidan, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12333 Ne 130th Lane, #320, Kirkland, WA 98034 Phone: 425-899-0555 Fax: 425-899-1333 |
Dr. Radha Saurabh Mehta, M.D Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12040 Ne 128th St, Kirkland, WA 98034 Phone: 425-899-1000 |
Dr. Xuanjing Zhou, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12333 Ne 130th Ln Ste 320, Kirkland, WA 98034 Phone: 913-972-3389 |
Dr. Karlyn B Huddy, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12333 Ne 130th Ln Ste 320, Kirkland, WA 98034 Phone: 425-899-0555 |
News Archive
Amgen (Nasdaq: AMGN) today announced detailed results from the Phase 3 '181' trial evaluating Vectibix((R)) (panitumumab) in combination with FOLFIRI (an irinotecan based chemotherapy), as a second-line treatment for metastatic colorectal cancer (mCRC). In this trial, Vectibix significantly improved progression-free survival (PFS) in patients with KRAS wild-type mCRC.
NanoLogix, a biotechnology innovator in the rapid detection and identification of live-cell microorganisms, announces preliminary results of MRSA testing at the University of Texas Health Science Center - Houston. Dr. Jonathan Faro, M.D., Ph.D. has found NanoLogix technology is able to deliver results for MRSA in 6 hours, as opposed to conventional culture-based testing wait times of 24 to 48 hours.
Priority Health has announced its coverage of both the seasonal flu and H1N1 flu vaccines. "Preventing the flu through immunization is the best way to keep yourself and your family healthy," said John Fox, M.D., associate vice president of Medical Affairs at Priority Health. "We encourage our members to receive both vaccines to protect themselves against the two viruses."
In 2016, more than 181,000 new cases of prostate cancer were reported in the U.S., according to the American Cancer Society. The prostate-specific antigen (PSA) test is one of the earliest ways clinicians can detect prostate cancers in their patients.
Researchers in Canada are reporting that proteins found in a common garden pea show promise as a natural food additive or new dietary supplement for fighting high blood pressure and chronic kidney disease (CKD).
› Verified 5 days ago